Elizabeth Masson's Insider Trades & SAST Disclosures

Elizabeth Masson's most recent trade in CorMedix Inc was a trade of 100,000 Stock Option (Right to Buy Common Stock) done . Disclosure was reported to the exchange on Feb. 18, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
CorMedix Inc
Elizabeth Masson EVP, Head of Clinical Ops. Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 100,000 100,000 - - Stock Option (Right to Buy Common Stock)
CorMedix Inc
Elizabeth Masson EVP, Head of Clinical Ops Sale of securities on an exchange or to another person at price $ 6.92 per share. 21 May 2021 8,000 0 (0%) 0% 6.9 55,394 Common Stock
CorMedix Inc
Elizabeth Masson EVP, Head of Clinical Ops. Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2021 140,000 140,000 - - Stock Option (Right to Buy Common Stock)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades